Title
Effects of hospital facilities on patient outcomes after cancer surgery: an international, prospective, observational study
Date Issued
01 July 2022
Access level
open access
Resource Type
journal article
Author(s)
Knight S.R.
Shaw C.A.
Pius R.
Drake T.M.
Norman L.
Ademuyiwa A.O.
Adisa A.O.
Aguilera M.L.
Al-Saqqa S.W.
Al-Slaibi I.
Bhangu A.
Biccard B.M.
Brocklehurst P.
Costas-Chavarri A.
Chu K.
Dare A.
Elhadi M.
Fairfield C.J.
Fitzgerald J.E.
Ghosh D.
Glasbey J.
van Berge Henegouwen M.I.
Ingabire J.C.A.
Kingham T.P.
Lapitan M.C.
Lawani I.
Lieske B.
Lilford R.
Martin J.
McLean K.A.
Moore R.
Morton D.
Nepogodiev D.
Ntirenganya F.
Pata F.
Pinkney T.
Qureshi A.U.
Ramos-De la Medina A.
Riad A.
Salem H.K.
Simões J.
Spence R.
Smart N.
Tabiri S.
Thomas H.
Weiser T.G.
West M.
Whitaker J.
Harrison E.M.
Gjata A.
Modolo M.M.
King S.
Chan E.
Nahar S.N.
Waterman A.
Vervoort D.
Bedada A.G.
De Azevedo B.
Figueiredo A.G.
Sokolov M.
Barendegere V.
Ekwen G.
Agarwal A.
Liu Q.
Camilo Correa J.
Malemo K.L.
Bake J.
Mihanovic J.
Kunčarová K.
Orhalmi J.
Salem H.
Teras J.
Kechagias A.
Arnaud A.P.
Lindert J.
Kalles V.
Aguilera-Arevalo M.L.
Recinos G.
Baranyai Z.
Kumar B.
Neelamraju Lakshmi H.
Zachariah S.K.
Alexander P.
Kumar Venkatappa S.
Pramesh C.
Amandito R.
Fleming C.
Ansaloni L.
Pellino G.
Altibi A.M.
Nour I.
Hamdun I.
Ghellai A.M.
Venskutonis D.
Poskus T.
Zilinskas J.
Malemia P.
Tew Y.Y.
Borg E.
Ellul S.
Publisher(s)
Elsevier Ltd
Abstract
Background: Early death after cancer surgery is higher in low-income and middle-income countries (LMICs) compared with in high-income countries, yet the impact of facility characteristics on early postoperative outcomes is unknown. The aim of this study was to examine the association between hospital infrastructure, resource availability, and processes on early outcomes after cancer surgery worldwide. Methods: A multimethods analysis was performed as part of the GlobalSurg 3 study—a multicentre, international, prospective cohort study of patients who had surgery for breast, colorectal, or gastric cancer. The primary outcomes were 30-day mortality and 30-day major complication rates. Potentially beneficial hospital facilities were identified by variable selection to select those associated with 30-day mortality. Adjusted outcomes were determined using generalised estimating equations to account for patient characteristics and country-income group, with population stratification by hospital. Findings: Between April 1, 2018, and April 23, 2019, facility-level data were collected for 9685 patients across 238 hospitals in 66 countries (91 hospitals in 20 high-income countries; 57 hospitals in 19 upper-middle-income countries; and 90 hospitals in 27 low-income to lower-middle-income countries). The availability of five hospital facilities was inversely associated with mortality: ultrasound, CT scanner, critical care unit, opioid analgesia, and oncologist. After adjustment for case-mix and country income group, hospitals with three or fewer of these facilities (62 hospitals, 1294 patients) had higher mortality compared with those with four or five (adjusted odds ratio [OR] 3·85 [95% CI 2·58–5·75]; p<0·0001), with excess mortality predominantly explained by a limited capacity to rescue following the development of major complications (63·0% vs 82·7%; OR 0·35 [0·23–0·53]; p<0·0001). Across LMICs, improvements in hospital facilities would prevent one to three deaths for every 100 patients undergoing surgery for cancer. Interpretation: Hospitals with higher levels of infrastructure and resources have better outcomes after cancer surgery, independent of country income. Without urgent strengthening of hospital infrastructure and resources, the reductions in cancer-associated mortality associated with improved access will not be realised. Funding: National Institute for Health and Care Research.
Start page
e1003
End page
e1011
Volume
10
Issue
7
Language
English
OCDE Knowledge area
Políticas de salud, Servicios de salud Oncología Cirugía
Scopus EID
2-s2.0-85131913282
PubMed ID
Source
The Lancet Global Health
Sponsor(s)
Funding text 1 MIvBH reports personal fees from Mylan, Alesi Surgical, Johnson and Johnson, and Medtronic; grants and non-financial support from Stryker; and grants from Olympus, outside the submitted work; all fees were paid to their institution. PB reports grants and personal fees from the Medical Research Council; grants from National Institute for Health Research (NIHR) Health Technology Assessment and the Wellcome Trust; and personal fees from AG Biotest, outside the submitted work. TPK reports personal fees from Olympus Surgical, outside the submitted work. All other authors declare no competing interests. Funding text 2 This study was funded by an NIHR Global Health Research Unit grant (NIHR 17-0799). The grant funded hub development in a subset of contributing countries. The views expressed are those of the authors and not necessarily those of the UK National Health Service, the NIHR, or the UK Department of Health and Social Care.
Sources of information: Directorio de Producción Científica Scopus